PRESS RELEASE published on 03/10/2025 at 06:58, 1 year 8 months ago Brockhaus Technologies AG: Clear growth in preliminary 2024 revenue to €205 million (+10% vs. 2023) with adjusted EBITDA of €66 million (+7% vs. 2023) Brockhaus Technologies AG reports clear growth in 2024 revenue to €205 million (+10% vs. 2023) and adjusted EBITDA of €66 million (+7% vs. 2023). Preliminary figures show solid performance amidst economic challenges Adjusted EBITDA Revenue Growth Organic Growth Brockhaus Technologies AG 2024 Financial Results
PRESS RELEASE published on 03/10/2025 at 03:30, 1 year 8 months ago A Majority of Businesses Intrigued by the Potential of AI in Achieving Sustainability Goals Whilst Energy Consumption Concerns Persist Survey by Alibaba Cloud reveals businesses' interest in leveraging AI and cloud computing for sustainability, highlighting energy consumption concerns and regional variations in adoption Cloud Computing Sustainability Goals AI Alibaba Cloud Energy Consumption
PRESS RELEASE published on 03/10/2025 at 00:00, 1 year 8 months ago CTT Pharma Uplists to the OTCQB Today CTT Pharmaceutical Holdings, Inc. (OTCQB: CTTH) joins OTCQB Market with innovative dissolvable strip technology for various actives like Nicotine and Pharmaceuticals. Incorporates micelle technology for drug delivery Drug Delivery OTCQB Market Micelle Technology CTT Pharmaceutical Holdings Dissolvable Strip Technology
PRESS RELEASE published on 03/09/2025 at 19:13, 1 year 8 months ago EEII AG: Reorganization of the Board of Directors EEII AG reorganizes its Board of Directors, separating the roles of CEO and Board to strengthen corporate governance. Christian Lüscher is the new Chairman, Alexandre Uldry remains CEO. Board reduced from 7 to 3 members Board Of Directors Corporate Governance Reorganization CEO EEII AG
PRESS RELEASE published on 03/08/2025 at 19:00, 1 year 8 months ago Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Positive pivotal data for Dupixent in bullous pemphigoid presented at AAD, showing significant disease remission and reduction in severity, itch, and medication use. Regulatory submissions under review in US and EU Dupixent Type 2 Inflammation Bullous Pemphigoid AAD Sustained Remission
PRESS RELEASE published on 03/08/2025 at 15:15, 1 year 8 months ago Icotrokinra Clinical Study Results Demonstrate Its Potential to Shift Treatment Paradigm and Set a New Standard for Treatment in Plaque Psoriasis Protagonist Therapeutics announces new data on icotrokinra in Phase 3 studies for moderate-to-severe plaque psoriasis. Launching first head-to-head study vs. ustekinumab Phase 3 Protagonist Therapeutics Plaque Psoriasis Icotrokinra Head-to-head Study
PRESS RELEASE published on 03/08/2025 at 00:54, 1 year 8 months ago Rektron Group's Trading Arm - DL Hudson's Non-Bank Lender, Artis Finance, Enters Administration Rektron Group Inc., a global commodity trading group, addresses the awareness of Artis Finance Ltd. entering administration in the UK. The company's trading arm remains stable with no material impact Administration Financial Stability Rektron Group Inc. Global Commodity Trading Artis Finance Ltd.
PRESS RELEASE published on 03/07/2025 at 22:50, 1 year 8 months ago Carbeeza Announces Appointment Of New Director Carbeeza Inc. appoints Mr. Tim Maddigan, a seasoned financial expert, to its board of directors, enhancing the company's leadership with extensive industry experience Technology AI Financial Services Carbeeza Inc. Tim Maddigan
PRESS RELEASE published on 03/07/2025 at 22:05, 1 year 8 months ago Organto Announces Reinstatement of Trading on the TSX Venture Exchange Organto Foods Inc. announces reinstatement of trading on the TSXV, following resolution of FFCTO. Company focuses on restructuring and improving balance sheet Restructuring TSXV Organto Foods Inc. Balance Sheet Reinstatement
PRESS RELEASE published on 03/07/2025 at 21:14, 1 year 8 months ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for 2024 at €205 million (+10% vs. 2023, -7% vs. forecast) and adjusted EBITDA at €66 million (+7% vs. 2023, -17% vs. forecast) Brockhaus Technologies AG reports preliminary revenue for 2024 of €205 million (+10% vs. 2023) and adjusted EBITDA of €66 million (+7% vs. 2023). Results below forecast due to operational challenges Adjusted EBITDA Revenue Preliminary Results Forecast Brockhaus Technologies AG
Published on 11/20/2026 at 15:00, 4 hours 22 minutes ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 4 hours 32 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 5 hours 22 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 5 hours 52 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 5 hours 52 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 19:03, 18 minutes ago EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group
Published on 11/20/2026 at 18:18, 1 hour 3 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary figures for FY 2025/26: Order intake above previous year, free cash flow positive; EBIT below guidance due to additional project costs in the gH2 segment
Published on 11/20/2026 at 17:35, 1 hour 47 minutes ago Guangzhou Nansha: GBA's strategic pivot for Asia-Pacific trade
Published on 11/20/2026 at 18:34, 47 minutes ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 47 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 hour 47 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 1 hour 47 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026